CDKN2A, also known as cyclin-dependent kinase inhibitor 2A, is a gene which in humans is located at chromosome 9, band p21.3. It is ubiquitously expressed in many tissues and cell types. From Wikipedia
Plans for phase I trials follow preclinical results showing that pairing PRMT5 inhibitors with MAP kinase blockers eradicates tumors lacking key suppressor genes
